Literature DB >> 15501801

Mucosal administration of flagellin induces innate immunity in the mouse lung.

Anna N Honko1, Steven B Mizel.   

Abstract

Nonsurgical intratracheal instillation of 1 microg of purified, recombinant flagellin in several strains of mice stimulated a transient innate immune response in the lung characterized by the infiltration of neutrophils and the rapid production of tumor necrosis factor alpha, interleukin 6, granulocyte colony-stimulating factor, and the chemokines keratinocyte-derived chemokine, MIP1alpha, and MIP-2.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15501801      PMCID： PMC523048          DOI： 10.1128/IAI.72.11.6676-6679.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  29 in total

1.  Intranasal administration of synthetic recombinant peptide-based vaccine protects mice from infection by Schistosoma mansoni.

Authors:  T Ben-Yedidia; R Tarrab-Hazdai; D Schechtman; R Arnon
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

2.  Synthetic recombinant influenza vaccine induces efficient long-term immunity and cross-strain protection.

Authors:  R Levi; R Arnon
Journal:  Vaccine       Date:  1996-01       Impact factor: 3.641

3.  Salmonella flagellin induces tumor necrosis factor alpha in a human promonocytic cell line.

Authors:  F Ciacci-Woolwine; I C Blomfield; S H Richardson; S B Mizel
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

4.  Intratracheal instillation method for mouse lungs.

Authors:  W Ho; A Furst
Journal:  Oncology       Date:  1973       Impact factor: 2.935

5.  Salmonellae activate tumor necrosis factor alpha production in a human promonocytic cell line via a released polypeptide.

Authors:  F Ciacci-Woolwine; L S Kucera; S H Richardson; N P Iyer; S B Mizel
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

6.  Role of flagella in pathogenesis of Pseudomonas aeruginosa pulmonary infection.

Authors:  M Feldman; R Bryan; S Rajan; L Scheffler; S Brunnert; H Tang; A Prince
Journal:  Infect Immun       Date:  1998-01       Impact factor: 3.441

7.  Flagellin from gram-negative bacteria is a potent mediator of acute pulmonary inflammation in sepsis.

Authors:  Lucas Liaudet; Csaba Szabó; Oleg V Evgenov; Kanneganti G Murthy; Pál Pacher; László Virág; Jon G Mabley; Anita Marton; Francisco G Soriano; Mikhail Y Kirov; Lars J Bjertnaes; Andrew L Salzman
Journal:  Shock       Date:  2003-02       Impact factor: 3.454

8.  Control of IL-12 and IFN-gamma production in response to live or dead bacteria by TNF and other factors.

Authors:  Y Zhan; C Cheers
Journal:  J Immunol       Date:  1998-08-01       Impact factor: 5.422

9.  Synthetic recombinant vaccine expressing influenza haemagglutinin epitope in Salmonella flagellin leads to partial protection in mice.

Authors:  J McEwen; R Levi; R J Horwitz; R Arnon
Journal:  Vaccine       Date:  1992       Impact factor: 3.641

10.  A murine model of cigarette smoke-induced pulmonary inflammation using intranasally administered smoke-conditioned medium.

Authors:  Laura M Miller; W Michael Foster; Donna M Dambach; Darryl Doebler; Murray McKinnon; Loran Killar; Malinda Longphre
Journal:  Exp Lung Res       Date:  2002-09       Impact factor: 2.459
View more
  58 in total

1.  A recombinant flagellin-poxvirus fusion protein vaccine elicits complement-dependent protection against respiratory challenge with vaccinia virus in mice.

Authors:  Kristen N Delaney; James P Phipps; John B Johnson; Steven B Mizel
Journal:  Viral Immunol       Date:  2010-04       Impact factor: 2.257

2.  Mucosal administration of flagellin protects mice from Streptococcus pneumoniae lung infection.

Authors:  Natalia Muñoz; Laurye Van Maele; Juan M Marqués; Analía Rial; Jean-Claude Sirard; José A Chabalgoity
Journal:  Infect Immun       Date:  2010-07-19       Impact factor: 3.441

Review 3.  Effects of flagellin on innate and adaptive immunity.

Authors:  Anna N Honko; Steven B Mizel
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

Review 4.  Flagellin as an adjuvant: cellular mechanisms and potential.

Authors:  Steven B Mizel; John T Bates
Journal:  J Immunol       Date:  2010-11-15       Impact factor: 5.422

5.  Flagellin, a TLR5 agonist, reduces graft-versus-host disease in allogeneic hematopoietic stem cell transplantation recipients while enhancing antiviral immunity.

Authors:  Mohammad S Hossain; David L Jaye; Brian P Pollack; Alton B Farris; Malefa L Tselanyane; Ebenezer David; John D Roback; Andrew T Gewirtz; Edmund K Waller
Journal:  J Immunol       Date:  2011-10-17       Impact factor: 5.422

6.  Mucosal adjuvant activity of flagellin in aged mice.

Authors:  John T Bates; Anna N Honko; Aaron H Graff; Nancy D Kock; Steven B Mizel
Journal:  Mech Ageing Dev       Date:  2008-02-17       Impact factor: 5.432

7.  A Novel R848-Conjugated Inactivated Influenza Virus Vaccine Is Efficacious and Safe in a Neonate Nonhuman Primate Model.

Authors:  Beth C Holbrook; Jong R Kim; Lance K Blevins; Matthew J Jorgensen; Nancy D Kock; Ralph B D'Agostino; S Tyler Aycock; Mallinath B Hadimani; S Bruce King; Griffith D Parks; Martha A Alexander-Miller
Journal:  J Immunol       Date:  2016-06-08       Impact factor: 5.422

8.  The alternative sigma factor AlgT represses Pseudomonas aeruginosa flagellum biosynthesis by inhibiting expression of fleQ.

Authors:  Anne H Tart; Matthew C Wolfgang; Daniel J Wozniak
Journal:  J Bacteriol       Date:  2005-12       Impact factor: 3.490

9.  Control of Pseudomonas aeruginosa in the lung requires the recognition of either lipopolysaccharide or flagellin.

Authors:  Reuben Ramphal; Viviane Balloy; Jeevan Jyot; Amrisha Verma; Mustapha Si-Tahar; Michel Chignard
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

10.  Flagellin-F1-V fusion protein is an effective plague vaccine in mice and two species of nonhuman primates.

Authors:  Steven B Mizel; Aaron H Graff; Nammalwar Sriranganathan; Sean Ervin; Cynthia J Lees; Mark O Lively; Roy R Hantgan; Michael J Thomas; James Wood; Brian Bell
Journal:  Clin Vaccine Immunol       Date:  2008-11-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.